Anti-CD20 monoclonal antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD20 monoclonal antibody therapy, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France